Perspective Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CATX and other ETFs, options, and stocks.About CATX
Perspective Therapeutics, Inc. is a medical technology and radiopharmaceutical company, which engages in the provision of treatment applications for cancers. The company was founded in 1983 and is headquartered in Seattle, WA.
CEOJohan M. Spoor
CEOJohan M. Spoor
Employees140
Employees140
HeadquartersSeattle, Washington
HeadquartersSeattle, Washington
Founded1983
Founded1983
Employees140
Employees140
CATX Key Statistics
Market cap198.11M
Market cap198.11M
Price-Earnings ratio-1.78
Price-Earnings ratio-1.78
Dividend yield—
Dividend yield—
Average volume1.86M
Average volume1.86M
High today$2.73
High today$2.73
Low today$2.57
Low today$2.57
Open price$2.63
Open price$2.63
Volume997.41K
Volume997.41K
52 Week high$5.39
52 Week high$5.39
52 Week low$1.60
52 Week low$1.60
Stock Snapshot
With a market cap of 198.11M, Perspective Therapeutics(CATX) trades at $2.67. The stock has a price-to-earnings ratio of -1.78.
On 2025-12-18, Perspective Therapeutics(CATX) stock traded between a low of $2.57 and a high of $2.73. Shares are currently priced at $2.67, which is +4.1% above the low and -2.2% below the high.
The Perspective Therapeutics(CATX)'s current trading volume is 997.41K, compared to an average daily volume of 1.86M.
During the past year, Perspective Therapeutics(CATX) stock moved between $1.60 at its lowest and $5.39 at its peak.
During the past year, Perspective Therapeutics(CATX) stock moved between $1.60 at its lowest and $5.39 at its peak.
Analyst ratings
93%
of 14 ratingsBuy
92.9%
Hold
7.1%
Sell
0%
People also own
Based on the portfolios of people who own CATX. This list is generated using Robinhood data, and it’s not a recommendation.